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Abstract  
Nodding syndrome (NS) is an emerging epidemic neurological disease that is shrouded in 
mystery. It is currently only found in the post-conflict regions of South Sudan, northern 
Uganda, and Tanzania. NS occurs in children from the ages of five to fifteen and is 
characterized by a loss of motor control in the neck muscles. Seizure episodes can range 
in intensity from atonic to tonic-clonic, and the onset of the first episode generally marks 
the beginning of a decline in the child’s physical and mental health. NS is a progressive 
disease that generally results in physical wasting, stunted growth, behavioral difficulties, 
and a decline in cognitive and motor skills. The underlying cause of the disease has yet to 
be soundly established, but several closely correlated factors have been discovered and 
effective treatment methods are currently being developed. Children with NS are also 
susceptible to detrimental social factors such as negative perception and stigmatization. 
Additionally, socioeconomic conditions greatly influence the ability of healthcare 
workers to identify and treat the disease.  
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The Plight of the Lucluc  
Examining the Deadly Mystery of Nodding Syndrome  
If you have ever been fortunate enough to visit the West African country of 
Uganda, you know firsthand how beautiful it is. You have seen its lush and fruitful 
greenery, its beautifully jagged mountains, and its expansive and sprawling lowlands. It 
is a place reminiscent of Eden; and many of the locals will claim that life did indeed 
begin at the source of the Nile, which lies in the heart of Uganda. Yet, in the northern 
region of the country, in the midst of all the beauty, lies a troubling mystery that is 
disrupting and destroying the lives of many African children and their families. This 
mystery is the epileptic disorder known as nodding syndrome (NS).  
In the early 1960s, this novel epileptic disorder was discovered in the sub-Saharan 
region of West Africa. Seizure victims were observed to lose motor control in the 
muscles of the neck prior to the onset of an episode (1). Initially this disorder was not 
independently studied or separated into a distinct clinical classification, as identical 
symptoms were rarely documented for almost half of a century.  The early 1990s, then, 
saw an alarming reemergence of this peculiar disease in the conflict-torn areas of South 
Sudan and northern Uganda, with isolated cases occurring in Tanzania. Currently, NS is 
classified as a distinct neurological condition and has recently been labeled as an 
epidemic by the Center for Disease Control and the World Health Organization (2). As of 
today, the exact pathological cause of the disease is still unknown, and much remains to 
be learned about the mechanisms of the disease. There is also no known cure at this 
juncture, but several promising treatment methods are being investigated. The purpose of 
this thesis is to explore the available literature dealing with NS and to examine the 
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characteristics, possible causes, current treatments, and social effects of this mysterious 
disease.  
History and Prevalence 
A type of seizure disorder characterized by the repetitive nodding of the head was 
first described in 1965 among the Wapogoro tribe in the Tanzanian highlands (3). A 
similar seizure disorder, with the onset of an episode characterized by a loss of motor 
control in the neck muscles leading to repetitive falling of the head toward the chest, was 
then described in 1983 (2). However, due to the rarity of the condition, unclear clinical 
records, and unreliable diagnoses this “head-nodding” disease did not receive its own 
classification until 1991 when it reappeared in South Sudan (4). Even with its own 
classification, NS was still such a rarely documented condition that it was not until it 
began to reach epidemic proportions in the late 2000’s that the world began to really take 
notice of the disease. In August 2012, the World Health Organization reached a 
consensus among the international scientific community for a case definition of NS (5). 
This definitive characterization of NS has greatly encouraged research into the mystery of 
NS by providing a much-needed measure of consistency when diagnosing patients 
suspected of suffering from NS.  
NS is currently considered to be an epileptic disorder of epidemic proportions by 
the World Health Organization (2). Unfortunately, accurate data detailing the exact 
number of cases has yet to be acquired. Combined data sets gained through journalistic 
efforts, evaluations by government and health officials, and independent medical studies 
place the number of cases of NS in the northern Ugandan districts of Kitgum, Pader, and 
Lamwo and the Equatoria States of South Sudan to be anywhere from 3,000 – 8,000 
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cases (2). Data on NS occurrence in South Sudan is even less precise, and rough 
estimates as to the disease’s prevalence in that region are highly inaccurate due to a lack 
of government infrastructure and public health systems from which to obtain records. To 
date, most studies into NS have focused on case studies or cohort studies using small 
samples of NS patients. No single study has yet been completed that accurately 
characterizes the full extent of the disease’s prevalence in sub-Saharan Africa. However, 
it is likely that the actual number of children with NS is far greater than the current 
records and estimates show. Given NS’s incidence in remote rural areas, there are likely 
large numbers of children who have yet to be identified and diagnosed. Currently, 
registration programs are being implemented in affected districts of Uganda to more 
accurately identify the spread of the disease, even in more remote regions, by keeping 
unified records of NS cases (6). Hopefully, this will provide an impetus for similar 
programs to be established in South Sudan so that the extent of the issue may be better 
understood.  
Characterization  
NS is named for its most distinguishable characteristic, an atonic seizure resulting 
in loss of neck muscle control that seems to cause the child experiencing the seizure to 
nod his or her head uncontrollably. However there is much more to the characterization 
of this disease than just this single physical manifestation. NS is classified as a form of 
childhood epilepsy and has currently only been observed in subtropical regions of sub-
Saharan Africa. The highest prevalence of the disease has been found in the Equatoria 
regions of South Sudan and the northern districts of Uganda. A few instances of the 
disease have been reported in Tanzania, though the epicenter of the disease has 
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consistently proven to be the 
Sudan. NS is classified as a childhood epilepsy because it h
occur in children 5 to 15 years of age
have been reported to contract the disease (See Figure 1). 
Figure 1: This graphic represents the age distribution of children with NS 
cohort study completed in the Kitgum district of Uganda by Foltz and colleagues. It should be 
noted that this is merely one district in one of the areas affected by NS and therefore is not a 
comprehensive evaluation of the age distribu
the largest cohort study compiled to date and therefore provides the best possible view of NS’s 
relationship to age. Modified from Foltz and Dowell. 
pg. 6. 2013) 
 
As previously stated, the hallmark of NS is the onset of an epileptic event 
resulting in the loss of motor control in the neck. The first occurrence of this type of 
atonic seizure is generally 
frequency of these nodding episodes can vary from a few times a week to several times a 
day. A general trend of increased frequency over time has been noted in several studies. 
Nodding episodes are classified as “head nodding” or “head nodding plus,” 
the particular characteristics of the episode. The “head nodding” classification indicates a 
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seizure with only the manifestation of features of NS, while a “head nodding plus” 
classification is used to describe a seizure possessing characteristics of NS, as well as 
characteristics of potentially several other epileptic type disorders (7).   Episodes 
garnering a “plus” designation occur in longsuffering NS patients and are commonly 
observed to consist of head nodding followed by generalized tonic-clonic seizures, which 
are separately classified from the characteristic atonic seizures regularly observed in NS 
due to the stiffening of muscle tone and spasticity of movement experienced by the 
patient (8). This demonstrates the progressive nature of NS if left unchecked. This 
progression is one of the most alarming features of the disease, and greatly contributes to 
the negative attritive effects of the illness.  
As the disease progresses, children with NS show marked physical, functional, 
sexual, and cognitive decline.  In some cases, nutritional and psychiatric deficits have 
also been noted in patients. A study was completed in 2013 by Richard Idro and 
colleagues detailing many of these developmental deficits in children with NS. According 
to their results, 73% of the NS patients they examined showed definite signs of physical 
wasting, with 41% showing marked signs of physical stunting. Patients exhibiting signs 
of wasting were shown to have had NS symptoms for three years or more, while severe 
wasting was associated with patients exhibiting symptoms for more than 7 years (8).  
Using the findings and observations of this study, Idro then proposed temporal 
stages of progression in NS. Stage 1 is called the prodromal period and includes the 
earliest symptoms of the disease, such as self-reported dizziness, increasing inattention, 
and lethargy. Stage 2 was found to occur approximately six weeks after Stage 1 and is 
characterized by the onset of head nodding episodes. Stage 3 does not occur in all NS 
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patients, and is characterized by the development of additional types of seizures. Among 
the cohort studied by Idro, Stage 3 was found to occur one to three years after the onset 
of the initial symptoms. Stage 4 was found to develop four to eight years after the onset 
of nodding episodes. This stage is marked by deterioration and decline in speech, motor, 
and cognitive functions, as well as a discernable regression in the child’s psychiatric 
behavior. Stage 5 is the final stage of the development of NS and is characterized by 
severe disability and wasting. Children in this stage exhibit severe physical wasting, 
mental apathy, severely limited communication ability, and poor appetites (9). It should 
be noted that not all children with NS experience all of these stages of progression. 
Recent treatment methods have been mildly successful in halting much of the progression 
of the disease; nevertheless these stages serve to show the types of devastation that this 
disease can wreak upon its victims if it is left unchecked. The mental and physical decline 
brought on by NS is an especially destructive aspect of this disease, as a majority of NS 
patients are at crucial stages in their development, and thus, because of the disease, will 
never fully develop physically or mentally.  
Possible Causes 
The most frustrating aspect of NS is also the very thing that makes it so 
fascinating; unfortunately the exact etiology of the disease is still very much a mystery. 
Like most epileptic disorders, the extreme complexity of the neurological system makes 
pathological studies difficult. However, much progress is being made towards a more 
complete understanding of the disease. Currently there are several plausible theories as to 
the causation of the disease. Exposure to opportunistic parasites, specifically the filarial 
worm Onchocerca volvulus, dietary deficiencies and toxicity, and psychosocial factors 
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have all been shown to correlate very closely with NS; genetic factors and family 
pedigrees have been examined in several studies but have yet to show any positive link or 
correlation. Common etiologies and pathologies found in other types of epileptic 
disorders have also been examined with extremely limited success. However, the several 
factors that have been found to positively correlate with NS have been used to formulate 
leading theories for the disease’s causation. It should be reiterated that these theories are 
currently based only on correlational data and can therefore remain only as well-
supported theories until scientific discovery provides repeatable causational links.  
I. Onchocerciasis  
For the past decade, the favorite etiological theory of many publications detailing and 
characterizing NS has been in some way linked to Onchocerciasis. Onchocerciasis, also 
known as “river blindness,” is a type of widespread parasitic infection that is commonly 
found in developing regions of the world. It is estimated that nearly thirty-seven million 
people in South America, sub-Saharan Africa, and tropical Asia are currently infected 
with the disease. (10). It is also the second leading cause of infection-related blindness in 
the world (11). The disease is named after the filarial nematode Onchocerca volvulus, 
which is responsible for the disease’s manifestation and pathology in humans. This 
particular parasitic worm is vector-borne and is carried by the common black fly of the 
Simulian genus (11). These black flies are common inhabitants of tropical areas and 
commonly breed in moving bodies of water, such as the rivers and streams of rural, 
agricultural areas. They pose a significant health risk to the villages and communities that 
greatly rely on these waters for survival. The parasite is transmitted to the host in its 
microfilariae form via the bite of the black fly. Once inside the human host, the 
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microfilariae invade the skin and migrate throughout it into other bodily locations, where 
they begin to grow and eventually produce the clinical manifestations of Onchocercal 
infection (10). Symptoms of infection are generally characterized by severe itching, skin 
lesions and disfiguration, sub-dermal nodules, and visual impairment leading to blindness 
(12). These symptoms are caused by the induction of an inflammatory response in the 
tissue where the parasite is present. The blindness that results from this disease is 
specifically caused by inflammatory damage to infected tissue in and around the cornea 
(10).  
Onchocercal infection has often been implicated as a possible factor in the 
etiology of NS. The reason for this implication is the consistently high correlation rates 
between children with NS and onchocerciasis exposure. A study published by Scott F. 
Dowell and colleagues provides one of the best characterizations of risk factors involved 
in NS currently available. According to the finding published in this study, which 
examined hundreds of NS patients in northern Uganda and Southern Sudan, ninety-three 
percent of Sudanese patients and ninety-five percent of Ugandan patients tested positive 
for O. volvulus (2).  
Currently, the leading hypothesis for this causational link between NS and O. 
volvulus is that the black flies populating the NS-endemic areas transmit a novel 
pathogen that may result in NS or other types of epileptic disorders (13). This theory is 
based on a recent paradigm shift in the understanding of Onchocerciasis infection. It has 
long been understood that a large majority of filarial nematodes, such as O. volvulus, 
possess a symbiotic relationship with an intracytoplasmic bacteria called Wolbachia (14). 
O. volvulus has been shown to rely on Wolbachia to achieve normal embryo 
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development, as well as to provide a continuing support system to aid the survival of the 
adult nematode in the host (15). Wolbachia have been shown to possess great genetic 
variability.  
At present, the high level of genetic deviation within the family has produced six 
distinct taxonomic groupings of the bacteria, with subdivisions having been established 
among each super group (16). One of the most common results of this genetic variation is 
the recombination of various surface proteins, which then explains the wide variety of 
physical traits and characteristics displayed by the organism (17). This is also a very 
significant factor in the relation of Wolbachia to Onchocerciasis, and ultimately to NS, 
because it is these surface proteins, serving as antigenic recognition sites for the immune 
system, which are partially responsible for the inflammatory immune response elicited 
against O. volvulus infection (15). Therefore, it is theoretically plausible that genetic 
differences in Wolbachia strains found in O. volvulus near NS-endemic regions could 
provoke a novel immune response that could possibly reveal a link between 
Onchocerciasis in those regions and the onset of NS. It has also been theorized by Robert 
Colebunders that perhaps a novel bacterial symbiont similar in function to Wolbachia is 
also spread via blackfly vector (18). Yet, at this current juncture, there has been no 
research into this line of hypothesizing.  
It should again be realized that O. volvulus involvement in the causation of NS is 
still merely hypothesis. The theory poses one glaring shortcoming: that Onchocerciasis 
infection is not localized to the regions affected by NS. As previously stated, it is a very 
widespread disease experienced in several different geographic locations. However, NS is 
endemic to only one region of the world, and has yet to be observed in any other regions 
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where Onchocercal infections are prevalent. Additionally, no direct clinical evidence has 
yet to provide a causational link showing how this filarial infection of O. volvulus would 
bring on the symptoms of NS. On the other hand, and in defense of the Onchocercal 
theory, recent research and observation has noted a marked decline in new diagnoses of 
NS coinciding with widespread vector control methods being implemented by the 
Ugandan government in northern Uganda to curtail the spread of black fly vector and its 
corresponding parasitic infection (13). With all this being said, Onchocerciasis is still a 
very intriguing possible explanation of the mystery of NS.  
II. Dietary Deficiencies 
Another theory behind the etiology of NS is the possibility of dietary deficiencies 
leading to the onset of the syndrome. An overwhelming majority of the children living 
with NS live well below international poverty lines, and therefore are rarely able to 
obtain the nutrients necessary for a balanced diet (4). One of the most promising dietary 
links to NS has been the recent characterization of pyridoxine (vitamin B6) deficiency in 
children with NS. Studies completed by the Center for Disease Control in Sudan and by 
Foltz and colleagues in northern Uganda showed ninety percent of patients examined 
with NS to also possess marked pyridoxine deficiencies (2, 19). This is a very important 
correlation as pyridoxine deficiency has been shown to be a factor in another type of 
epileptic disorder affecting pediatric patients, pyridoxine-dependent epilepsy (PDE). PDE 
is a rare genetic disorder that affects children from the ages of several months to three 
years. PDE is caused by a mutation in the ALDH7A1 gene, which results in the 
malformation of a dehydrogenase enzyme responsible for the breakdown of the amino 
acid lysine in the brain. It is readily and effectively treated through the usage of daily 
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administrations of pyridoxine supplements (20). While the genetic aspect of the disease 
makes PDE clinically variable from NS, and therefore not a perfect link between the two, 
the model of PDE provides an example of the disruption of a metabolic pathway 
involving pyridoxine leading to neurological disruption.  
Various other dietary factors have been loosely linked to NS. Ingestion of toxic 
substances has often been cited as a possible cause of the disease. However, correlational 
data has yet to produce substantial evidence to back this particular hypothesis. Currently, 
the most plausible link to nutritional toxicity as a factor in NS is the common 
consumption of the staple crop cassava. Cassava is a root commonly grown and 
consumed in sub-Saharan Africa because of its resistance to famine, plant disease, and 
pests. While this hardy quality makes it a very beneficial crop, especially in areas of 
poverty and drought, it can be deadly if not properly prepared. Undercooked or bitter 
cassava has been shown to lead to cyanide production in the body (21). The production of 
this neurotoxin has been shown to be a causative factor in several neurological disorders 
found in NS endemic regions. This provides a very relevant precedence for dietary 
factors leading to neurologic disorders, specifically in that part of the world, and it could 
prove to be a useful model in formulating further hypotheses regarding causative factors 
of NS.  
III. Violence  
Perhaps the most intriguing and complex theory as to the causation of NS lies in 
the ostensible correlation of a localized epidemic with the extreme violence and civil war 
of the region’s recent history. Northern Uganda is still in the process of recovering from 
years of war and civil unrest between Ugandan government forces and Joseph Kony’s 
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Lord’s Resistance Army (LRA). This conflict lasted, roughly, from 1986 to 2008, which 
closely coincides with NS’s rise to prominence from the late 1990’s to the present day 
(22). Sudan has also been in an almost constant state of turmoil, due to religious and 
cultural conflicts, as well as various civil wars and government upheaval, since the 
1950’s (23). Because of these conflicts, both of these regions have experienced extreme 
violence in which citizens experienced widespread physical and psychological abuses 
were major factors. Many of the stories that have come from survivors of these conflicts 
are almost too terrible to fathom. Reports of violent wartime death, murder, rape, 
cannibalism, abduction, slavery, and other such terrible atrocities have all surfaced from 
these war-torn regions.  
Because of the traumatic nature of these atrocities and the severe psychological 
stress brought about by living under such conditions, many of the inhabitants of these 
regions and the peoples displaced by these conflicts have experienced some sort of 
psychological damage. A study by Bayard Roberts and colleagues published in 2008 is 
one of the largest and most revealing studies into the psychological collateral damage that 
these particular regions experienced. For the study, Roberts visited internally displaced 
persons (IDP) camps in the conflict-plagued regions of Gulu and Amuru in northern 
Uganda. Cross-sectional cluster surveys were completed on over twelve hundred 
displaced persons using a questionnaire developed by Harvard University to test for post-
traumatic stress disorder (PTSD) and another questionnaire developed by Johns Hopkins 
to determine stages of depression. The results of the survey showed that 54% of the IDP 
camp residents met the established criteria to be diagnosed with PTSD, and 67% of 
surveyed individuals also met the symptomatic criteria linked to depression (24). This 
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study serves to provide tangible evidence of widespread psychological effects that have 
yet to be fully quantified. Roberts and colleagues also completed an identical study in 
South Sudan using the same questionnaire and survey methods to determine mental 
health status among refugees. The results of this study showed 36% of individuals 
surveyed met symptomatic criteria for PTSD and 50% met criteria for depression (25). 
While these tests are merely a small sample of the hundreds of thousands of people 
affected by the violence, they do provide insight into the psychological state of the 
populations in these regions. Therefore, because NS is endemic to these areas of high 
violence, it is not out of the realm of possibility that NS may have some sort of 
psychological link that has yet to be fully understood.  
The correlation of NS with wartime violence is further supported by the temporal 
association of violent conflict and number of deaths with new diagnoses of NS (See 
Table 1 and Figure 2). This relationship has been best characterized by a statistical 
analysis completed by Jesa Landis and colleagues in 2014 that shows the delayed onset of 
NS following violent activities in the Kitgum district of Uganda (See Figure 2). 
According to the data produced in this study, cases of NS first appeared in 1998, 
following several highly violent LRA massacres. NS diagnoses then increased again, and 
reached a peak in 2004 following several years of intense conflict and high mortality 
rates. Another peak of NS diagnosis was then reached in 2008. This also followed the 
upward trend of increased prevalence of NS following times of high violence. The data 
also shows a decline in new diagnoses of the disease following prolonged periods of 
peace, which would be expected if the disease were proven to be related to psychological 
duress (26). The correlational connection between NS and violence was also detailed in 
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aforementioned studies by Dowell and Foltz. According to the findings of these studies a 
majority (71% in the Foltz study and 54% in the Dowell study) of patients examined with 
NS had been directly exposed to firsthand military violence. While both of these studies 
were completed under the presuppositions of a previously held hypothesis that munitions 
exposure may play a role in NS development, they still serve to provide data linking 
wartime violence to NS (2, 19). Together, the data and evidence collected in these studies 
serve to provide a very good case for a psychological factor in the onset of NS.  
 
Table 1: Annual Incidence of Violence, Fatalities, and Novel Diagnosis of NS in Uganda   
Year 
Violent 
Occurrences Fatalities New Cases of NS 
*1997 22 128 0 
*1998 57 143 3 
1999 13 31 2 
2000 19 70 5 
2001 8 0 4 
*2002 42 115 25 
*2003 53 167 38 
2004 33 87 42 
2005 21 55 36 
2006 8 45 52 
2007 2 0 70 
2008 1 10 82 
2009 0 0 62 
2010 0 0 46 
2011 1 0 0 
 
Table 1: This data provides the means to observe the correlation of violent events and fatalities 
with new diagnoses of NS in Uganda. The data was accumulated from Armed Conflict Location & 
Event Data with assistance from the Uganda Ministry of Health. Asterisks are used to signify 
dates of particularly violent occurrences. 1997-1998 saw a large number of deaths and marked 
violence due to the regular occurrence of LRA abductions and massacres throughout the northern 
districts. 2002-2003 was the peak of violent conflict between the LRA and Uganda national forces, 
also known as Operation Iron Fist (26). Modified from Raleigh and Landis (27)(26 pg 3). 
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Figure 2: Correlational relationship of violence and fatalities with the onset of new NS cases
Figure 2: This Figure shows the correlational and temporal relationship of violence and fatalities 
with the increased occurrence of NS. The data used to compile this chart was obtained from the 
information found in Table 1. It should be noted that the inci
following a time of high violence. Conversely, new incidence of the disease declines rapidly 
during times of peace. Modified from Landis 
Because the exact etiology of NS has not yet been disco
detail one single efficacious treatment plan for all patients with the disease. At this 
juncture, clinicians and physicians are forced to combat the disease using asymptomatic 
treatment methods that can vary depending on the sp
Idro and colleagues in association with Makerere Medical School in Uganda first 
proposed detailed treatment guidelines designed to encompass t
mental aspects of NS. These methods include anti
to combat filarial infection, dietary supplementation, and physical and cognitive 
 
dence of NS markedly increases 
(26, pg. 3).  
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therapeutic techniques. No one solution has been found to be completely effective, 
however, several multi-faceted treatment approaches have recently proven very 
successful in clinical trials.  
The socioeconomic climate in which NS is prevalent also brings forth its own 
unique trials in regards to attempts at combatting the disease. Because a large number of 
individuals with NS subsist at or well below poverty lines, and because of structural 
instability found in communities experiencing NS due to civil unrest, treatment is often 
impossible outside of government programs or non-government organization aid. 
Additionally, NS is a fairly new, emerging disease with relatively little research and 
study having been published on the subject. While it has received some media attention, 
it is still mostly unheard of in most public circles. This provides a unique challenge for 
many healthcare workers dealing with the problem of NS, as funding and resources 
needed to advance treatment methods and purchase medical supplies necessary for 
current NS treatment methods are difficult to procure.   
I. Anti-Epileptic Drugs  
Anti-epileptic drugs have been used to manage the onset of seizures in NS 
patients, but unfortunately, their success has been limited and consistency of results has 
yet to be achieved. The characteristics of NS make it a difficult target for drug treatment. 
An efficacious drug is necessary first and foremost, but because of economic factors, the 
pediatric demographic of affected patients, and the disease’s unique characteristics, the 
drug also must be inexpensive, safe, and possess the ability to combat multiple seizure 
types. Currently, phenobarbitone, phenytoin, and carbamazepine are the three anti-
epileptics most often used in clinical treatment of NS. However, only limited success has 
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been obtained. In clinical trials completed by Andrea Winkler and colleagues in 2013 and 
in 2014, the efficacy of these various anti-epileptics was examined. In these studies, the 
results greatly varied, so a definite conclusion regarding the most effective drug treatment 
method was not reached. However, all three of the aforementioned drugs were utilized, 
and were found to markedly reduce seizure frequency. It was also found in the 2013 
study that around 40% of patients treated with either phenobarbitone or carbamazepine 
ceased seizure activity all together (28, 29). The limitation of these particular studies is 
the small sample size that was examined, however their results do point to the possibility 
of an effective method of NS control through the use of antiepileptic drugs. Sodium 
valproate has also been suggested as another possible drug treatment because of its wide 
range of efficacy and activity against behavioral difficulties, but it has yet to be tested in 
clinical trials. In summary, while several drug treatment methods have been examined, 
with a few showing some promise, a truly efficacious anti-epileptic drug against NS has 
yet to be found.  
II. Vector Control 
Because of the close correlation of NS with Onchocerciasis, it is believed that 
elimination of the O. volvulus carrying black fly vector could potentially also eliminate 
the onset of NS. The theory behind this is that if the only way for onchocerciasis to be 
spread is through its black fly vector, then the disease’s spread will be stopped if the 
vector is eliminated. In 1997, the African Program for Onchocerciasis Control decided 
upon a community-directed ivermectin treatment program to eliminate the spread of the 
disease. This program made ivermectin directly available to communities affected by the 
filarial disease. However, because of the violence and instability experienced in the 
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northern regions of Uganda and in South Sudan this treatment often could not be 
delivered. Since emerging from these conflicts, both of these regions have been able to 
benefit from the communal distribution of ivermectin. In 2012, the Ugandan Ministry of 
Health began to implement widespread environmental treatments, using boats and planes 
to spread the organophosphate Temephos into local river systems. While a causal link has 
yet to be established, these vector control measures have coincided with a drastic drop in 
the onset of new cases of NS in Uganda (13). At this juncture, there is no data detailing 
the effect of vector control methods in Sudan, but given the results obtained in Uganda, it 
is suggested that similar protocols be followed in that particular region as well. It should 
also be noted that this protocol is merely a preventative measure. If vector control does 
indeed prohibit the spread of NS, it still does nothing for those thousands of children that 
have already contracted the disease.   
III. Multi-faceted Approaches 
 Because of a greater understanding of NS, clinicians are now able to utilize 
multifaceted approaches to more effectively treat the full range of NS symptoms. In an 
exciting study completed at the end of 2014 by Idro and colleagues, a multi-faceted 
approach, consisting of both mental and physical care, was used to treat a group of NS 
patients. Sodium valproate was used to combat the onset of seizure. Dietary 
considerations were taken into account, and the patients were provided with nutritional 
supplements consisting of proteins and essential vitamins and minerals. Patients with 
emotional and behavioral problems were brought into counseling and provided with 
mental health services. Many of these patients were then subjected to physical therapy 
and cognitive stimulation. This approach proved to be successful as several of the 
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patients were found to have achieved seizure freedom after seven months of therapy. 
Adding to this success, over 70% of patients in Idro’s study achieved remission of 
seizures (30). This study provides great impetus for further development of this treatment 
method, as a more holistic approach may yet provide the key to stopping NS.  
Social Aspects 
One of the most devastating effects of NS is not found in its physiological damage 
or in any of its destructive cognitive impairments, but in the negative stigma and harmful 
stereotyping that have become as much a part of the disease as its pathological 
manifestations. This stigma is far-reaching and goes beyond the views of those on the 
outside observing the disease and extends to the families and even the physicians and 
nurses who are ultimately tasked with caring for the children suffering with the disease. 
This stigma and stereotyping is a very complicated issue that stems from a mixture of 
cultural and religious ideologies and a lack of fundamental education on the subject.  
Mental and epileptic diseases have long been plagued with misconception. The 
ancient Babylonians recorded in stone tablets accounts of epileptic disorders, which they 
claimed were brought about by supernatural forces of evil (31). The Greek historian 
Herodotus posited that the wicked deeds committed by the Persian King Cambyses II 
brought about his judgment in the form of epileptic and mental disorders (32). In the 
Islamic kingdoms of modern day Saudi Arabia and Turkey, possession by a Jinn was 
thought to bring about epileptic seizures (33). Hippocrates was one of the first ancient 
thinkers to discredit entirely the notion of supernatural forces, as he hypothesized that 
most mental disorders, including epilepsy, were brought about by an excess of the bodily 
humor phlegm circulating in the blood, which would in turn cause a buildup of phlegm in 
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the brain (34). Even though the world medical profession has come a long way since the 
time of antiquity, much of the negative stigma attached to epileptic disorders is still very 
prevalent in societies and cultures throughout the world today. Given the mysterious and 
disruptive nature of NS, this negative stigma is far too often placed squarely upon many 
of the children with this disease.  
In comparison with similar studies based in the United States and other developed 
nations, there is very little qualitative and quantitative data, which addresses the issue of 
social stigma toward those with epilepsy. However, several studies have been published 
demonstrating the negative views held by many in sub-Saharan Africa towards those with 
epileptic disorders and NS specifically. These studies serve to highlight the social harm 
that these pervasive beliefs continue to bring upon people, families, and communities 
affected with these types of ailments.  
In sub-Saharan Africa, a region that constitutes the epicenter of NS, several 
misinformed and errant views have led to the formation of many different, and often 
harmful, belief systems pertaining the origins and causations of such epileptic disorders. 
Many in this area of the world attribute the frightening onset of a seizure disorder to 
supernatural means, with evil spirits, curses, and sorcery most often cited as the causative 
agent (35). This is generally due to deep-rooted traditional religious beliefs that still very 
much hold to animistic and spiritual ideology. This usually results in spiritual help being 
sought by the afflicted patient well before any actual medical assistance. To give a loose 
idea as to the widespread incidence of these practices, a study done by Gretchen Birbeck 
of UCLA posited that over 70% of the people of Zambia (a country neighboring the NS 
locus) would seek traditional help regarding epileptic disorders. This number was also 
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expected to greatly increase in more rural areas where even lower levels of education 
generally exist. Furthermore, of persons with epilepsy encountered during Birbeck’s 
study, less than four percent reported that they had sought modern medical help for their 
seizure disorder (36). This is problematic as many of the practices of traditional healers 
or medicine men are often detrimental to the health of a patient and can oftentimes lead to 
further complications. For example, in the case of children suffering from febrile 
seizures, typically brought about by malarial infection, children who were first taken to 
traditional healers possessed much higher levels of parasitemia and generally required 
much longer hospital stays and more treatment than children that were first taken to 
medical professionals (35). Unfortunately, this supernatural attribution and stigmatization 
does not begin and end with the common layperson, but it also extends to those more 
educated as well.  
Several studies have been published regarding stigmatization and its effects on the 
presuppositions of healthcare workers and primary caregivers who are directly tasked 
with assisting children suffering with the disease.  In one study by Mutamba and 
colleagues, one hundred health professionals from the three districts in Uganda most 
affected by NS were asked a series of interview questions designed to reveal underlying 
bias. Those participating in this study included doctors, nurses, clinical officers, and 
laboratory technicians. Of the one hundred individuals polled, over sixty-five percent 
believed that the disease was linked to evil spirits. Eighty-percent believed that NS is 
incurable and there is ultimately nothing that can be done for those with the disease. 
Other alarming responses surfaced throughout the interview that further betrayed 
underlying negative bias against children with the disease. One registered nurse 
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communicated her opinion that, “…children with this disease are useless, they cannot do 
anything for themselves.” Another community health officer expressed his view that 
“these children are a burden to the community, parents cannot work because of them…” 
(37). This negative perception is very problematic because it is so pervasive amongst 
those tasked with trying to alleviate this condition. These negative perceptions and 
unfounded beliefs may then have a direct negative effect upon the quality of patient care. 
What is more, those in the health care community are looked to as examples of proper 
response toward many diseases. If these professionals’ response is based in fear and 
ignorance, the response of the general public will in many ways mirror it.  
Another recent study, published in early 2015 by Kristine Buchman, reveals much 
of the same stigmatization among those close to children with NS, such as parents, close 
relatives, teachers, and religious leaders. Buchman’s study used an interview method 
similar to Mutamba’s, in which questioning was used to better understand the experience 
of caring for a child with the disease. This line of questioning resulted in many negative 
responses similar to those elicited in the Mutamba study, but also shed some light into 
other fears and misconceptions surrounding children with the disease. It was revealed that 
many of the subjects in the study were afraid to directly assist the child with NS in the 
event of an episode because they feared that the disease was contagious. One teacher 
reported that, “The only thing for us we can do, normally when a child falls this side 
maybe when the wind is blowing the other side, we make children move away from 
where the wind is going. Because we might be thinking it's going to infect them through 
air.” A brother of a child with NS also related his fear of the unknown nature of the 
disease, saying, “You know when these childrens [sic] are having this nodding attack you 
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can see the saliva coming out from their mouth, and the belief is that maybe that saliva 
contains something that actually contains the germs that cause epilepsy” (38).  
According to the many other interviews conducted by Buchman, these 
misconceptions are not just isolated ideas, but widely held beliefs among communities 
that have been exposed to the disease. There were many reported cases of children being 
excluded from group play with peers, as well as many instances of name-calling, and 
derogatory references directed at children with the disease.  In northern Uganda these 
children are often referred to as “lucluc” which loosely translates to “head-nodder” (39). 
An earlier study by Buchmann, conducted using the same interview based methods, 
found that this derision and exclusion did not begin and end with other children and 
playmates, but could also extend into the adult realm and affect more serious matters 
such as exclusion from school admission and community activities (40).  
This stigmatization does not only affect the child with the disease, but also greatly 
affects their families. Most caregivers in the 2015 Buchmann study reported a dramatic 
reduction in the amount of visitors they received at their homes, and that any visitors 
would adamantly refuse to eat, drink, or stay the night (38). According to the earlier 
Buchmann study, this community-wide isolation comes from the traditional African way 
of thinking that, in regards to disease, the question is generally “who is responsible for 
my sickness?” not “what is responsible for my sickness?” (40). This widespread 
community-based stigmatization makes life very difficult for families with children with 
NS, and in many cases, according to both Mutamba and Buchmann, it can lead to 
caregivers hiding their children away instead of seeking the proper professional help (37, 
38). This may then mean that many children with NS will never receive the care that they 
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so desperately need as long as these harmful and extremely negative stigmas are allowed 
to dominate these particular communities.  
 Conclusion  
At the beginning of this paper it was stated that this thesis represented a review of 
literature serving to examine the mystery of NS. While this may be the direct purpose of 
the paper, it is in no way the exclusive purpose. For the overall subject is not a 
mysterious disease, but about assisting the thousands of children affected by that 
mysterious disease. It is highly probable that before reading this paper you had never 
heard of NS, for this is the case for many on the western side of the Atlantic. Sadly, many 
of those affected by NS lack the voice with which to plead their case. Children with this 
disease are almost always outcasts from their community and have no platform from 
which to be heard. Therefore, because of a worldwide ignorance to their condition, 
thousands of children are forced to slowly waste away, mentally and physically, beneath 
the crushing weight of their mysterious disease. These children need a voice with which 
to cry out and be heard. They need advocacy among those with the power and pull to 
initiate change and provide aid. However, this advocacy cannot be achieved without 
knowledge of the issue. The world must first be made aware of these nodding children 
before it can act on their behalf. Because with awareness comes hope and the potential 
for a spark to be lit that will lead to a flame that clearly illuminates the plight of the 
lucluc.  
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